WallStreetZenWallStreetZen

NYSE: CAH
Cardinal Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CAH

Based on 11 analysts offering 12 month price targets for Cardinal Health Inc.
Min Forecast
$64.00-16.92%
Avg Forecast
$79.46+3.15%
Max Forecast
$94.00+22.03%

Should I buy or sell CAH stock?

Based on 11 analysts offering ratings for Cardinal Health Inc.
Buy
Strong Buy
3 analysts 27.27%
Buy
2 analysts 18.18%
Hold
6 analysts 54.55%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CAH stock forecasts and price targets.

CAH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Credit Suisse
Bottom 8%
8
HoldMaintains$92.00+19.43%2023-02-03
Morgan Stanley
Top 4%
97
Strong BuyMaintains$90.00+16.84%2023-02-03
Baird
Bottom 20%
20
BuyUpgrades$94.00+22.03%2023-02-03
UBS
Top 27%
74
Strong BuyMaintains$91.00+18.14%2023-01-31
Credit Suisse
Top 6%
95
HoldMaintains$79.00+2.56%2022-11-22
Mizuho
Top 12%
89
HoldMaintains$74.00-3.93%2022-11-14
Bank of America
Bottom 15%
15
HoldUpgrades$80.00+3.86%2022-11-04
Cowen & Co.
Top 30%
71
HoldMaintains$72.00-6.53%2022-08-16
Morgan Stanley
Top 3%
98
Strong BuyMaintains$70.00-9.13%2022-07-14
Barclays
Top 29%
72
HoldDowngrades$64.00-16.92%2022-05-26

1 of 2

Forecast return on equity

Is CAH forecast to generate an efficient return?
Company
-69.97%
Industry
-440.12%
Market
47.78%
CAH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CAH forecast to generate an efficient return on assets?
Company
3.48%
Industry
5.36%
CAH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CAH earnings per share forecast

What is CAH's earnings per share in the next 2 years based on estimates from 7 analysts?
Avg 1 year Forecast
$5.34
Avg 2 year Forecast
$6.01

CAH revenue forecast

What is CAH's revenue in the next 2 years based on estimates from 5 analysts?
Avg 1 year Forecast
$192.6B-0.19%
Avg 2 year Forecast
$202.5B+4.93%
CAH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CAH revenue growth forecast

How is CAH forecast to perform vs Medical Distribution companies and vs the US market?
Company
-0.19%
Industry
1.48%
Market
72.18%
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CAH vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
CAH$77.03$79.46+3.15%Buy
HSIC$86.23$88.63+2.78%Hold
ABC$154.49$180.17+16.62%Strong Buy
PBH$60.82$68.25+12.22%Strong Buy
PDCO$29.73$36.40+22.44%Buy
View Top Medical Distribution Stocks

Cardinal Health Stock Forecast FAQ

Is Cardinal Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NYSE: CAH) stock is to Buy CAH stock.

Out of 11 analysts, 3 (27.27%) are recommending CAH as a Strong Buy, 2 (18.18%) are recommending CAH as a Buy, 6 (54.55%) are recommending CAH as a Hold, 0 (0%) are recommending CAH as a Sell, and 0 (0%) are recommending CAH as a Strong Sell.

If you're new to stock investing, here's how to buy Cardinal Health stock.

What is CAH's earnings growth forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 12.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 85.2%.

Cardinal Health's earnings in 2023 is -$1,273,000,000.On average, 7 Wall Street analysts forecast CAH's earnings for 2023 to be $1,375,792,575, with the lowest CAH earnings forecast at $1,331,993,935, and the highest CAH earnings forecast at $1,473,695,417.

In 2024, CAH is forecast to generate $1,548,410,745 in earnings, with the lowest earnings forecast at $1,465,966,246 and the highest earnings forecast at $1,628,278,853.

What is CAH's revenue growth forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's forecast annual revenue growth rate of -0.19% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 1.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 72.18%.

Cardinal Health's revenue in 2023 is $193,011,000,000.On average, 5 Wall Street analysts forecast CAH's revenue for 2023 to be $49,630,806,133,577, with the lowest CAH revenue forecast at $48,176,442,920,528, and the highest CAH revenue forecast at $51,563,417,517,954.

In 2024, CAH is forecast to generate $52,180,284,262,752 in revenue, with the lowest revenue forecast at $50,061,845,554,290 and the highest revenue forecast at $54,454,024,704,310.

What is CAH's forecast return on assets (ROA) for 2023-2024?

(NYSE: CAH) forecast ROA is 3.48%, which is lower than the forecast US Medical Distribution industry average of 5.36%.

What is CAH's Price Target?

According to 11 Wall Street analysts that have issued a 1 year CAH price target, the average CAH price target is $79.46, with the highest CAH stock price forecast at $94.00 and the lowest CAH stock price forecast at $64.00.

On average, Wall Street analysts predict that Cardinal Health's share price could reach $79.46 by Feb 3, 2024. The average Cardinal Health stock price prediction forecasts a potential upside of 3.15% from the current CAH share price of $77.03.

What is CAH's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: CAH) Cardinal Health's current Earnings Per Share (EPS) is -$4.67. On average, analysts forecast that CAH's EPS will be $5.34 for 2023, with the lowest EPS forecast at $5.17, and the highest EPS forecast at $5.72. In 2024, CAH's EPS is forecast to hit $6.01 (min: $5.69, max: $6.32).

What is CAH's forecast return on equity (ROE) for 2023-2024?

(NYSE: CAH) forecast ROE is -69.97%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.